Fairmount Partners Advises Accugenix in Sale to Charles River Laboratories Friday, August 24, 2012 NEWARK, DE – August 24, 2012 –Accugenix, the global leader in cGMP compliant microbial identification testing, has been acquired by Charles River Laboratories (NYSE: CRL), a provider of essential products and contract services to that advance drug discovery and development. Headquartered […]

Fairmount Partners Assists TTC, a Leading Clinical Trial Analytics Business, in Sale to IMS Tuesday, August 14, 2012 PHILADELPHIA, PA — IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust […]

Caprion Proteomics, Inc. Completes Recapitalization Friday, July 20, 2012 Montreal, Quebec – Chicago Growth Partners has completed a recapitalization of Caprion Proteomics, Inc., a leading provider of integrated proteomic biomarker and target identification solutions and advanced immune monitoring services to the world’s largest and most successful pharmaceutical and biotechnology companies as well as government research […]

Halliburton Acquires Petris Technology Inc. Fairmount Partners represented Petris Technology, a leading supplier of data management and integration solutions to the global energy industry, as their exclusive financial advisor in completing the transaction below. Petris Technology was a portfolio company of Kayne Anderson Capital, a private equity firm based in Los Angeles. Official Press Release: […]